Please Upload related files below
Fill in below.
Tell us the stocks you own using Snaptrade, and we will keep you informed about class action litigation related to your stocks. We monitor critical case developments that may affect the price of your shares and your possible monetary recovery. Snaptrade only shares the tickers you own and your transaction history, not your account numbers. Using Snaptrade and participating in our monitoring service is free and does not create any attorney-client relationship or obligation on your part.
Don’t miss out on possible monetary recovery- link your account with Snaptrade.
Levi & Korsinsky announces it has commenced an investigation of Reliq Health Technologies Inc. (“Reliq” or “the Company”) (OTCMKTS: RQHTF) concerning possible violations of federal securities laws.
On October 16, 2018, Reliq issued a press release announcing it would restate financial information reported for the quarter ended March 31, 2018 after a review conducted by the Company’s auditor and Audit Committee determined that the “timing and certainty of receiving the revenue invoiced to clients is substantially unclear, due to clients’ issues with securing reimbursement from the payor.” Reliq also stated that the changes would “affect the Company’s revenue and are projected to increase the Company’s loss and comprehensive loss for Fiscal Year 2018.” On this news, shares of Reliq stock fell more than 55% to close at $0.26 per share on October 16, 2018.